vs
FIRST US BANCSHARES, INC.（FUSB）与TriSalus Life Sciences, Inc.（TLSI）财务数据对比。点击上方公司名可切换其他公司
TriSalus Life Sciences, Inc.的季度营收约是FIRST US BANCSHARES, INC.的1.3倍（$13.2M vs $10.4M），FIRST US BANCSHARES, INC.净利率更高（20.4% vs -73.9%，领先94.3%），TriSalus Life Sciences, Inc.同比增速更快（59.8% vs 7.1%），FIRST US BANCSHARES, INC.自由现金流更多（$9.1M vs $-2.5M），过去两年TriSalus Life Sciences, Inc.的营收复合增速更高（43.0% vs 2.6%）
第一美国银行控股公司是一家银行控股企业，核心子公司第一公民银行在美国23个州经营着超过500家网点，另一家子公司硅谷银行则在15个州设有39个办事处，是美国规模较大的银行机构之一，总部位于北卡罗来纳州罗利。
TriSalus生命科学公司是一家临床阶段生物技术企业，专注于免疫肿瘤学与介入肿瘤学领域，研发专有的靶向给药技术，用于提升肝脏、胰腺等难治性实体瘤患者的治疗效果，主要在北美市场开展临床合作及业务运营。
FUSB vs TLSI — 直观对比
营收规模更大
TLSI
是对方的1.3倍
$10.4M
营收增速更快
TLSI
高出52.8%
7.1%
净利率更高
FUSB
高出94.3%
-73.9%
自由现金流更多
FUSB
多$11.6M
$-2.5M
两年增速更快
TLSI
近两年复合增速
2.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.4M | $13.2M |
| 净利润 | $2.1M | $-9.8M |
| 毛利率 | — | 86.7% |
| 营业利润率 | 28.1% | -24.8% |
| 净利率 | 20.4% | -73.9% |
| 营收同比 | 7.1% | 59.8% |
| 净利润同比 | 24.2% | 3.5% |
| 每股收益（稀释后） | $0.36 | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FUSBTLSI
| Q4 25 | $10.4M | $13.2M | ||
| Q3 25 | $10.5M | $11.6M | ||
| Q2 25 | $10.3M | $11.2M | ||
| Q1 25 | $9.8M | $9.2M | ||
| Q4 24 | $9.7M | $8.3M | ||
| Q3 24 | $10.1M | $7.3M | ||
| Q2 24 | $10.0M | $7.4M | ||
| Q1 24 | $9.9M | $6.5M |
净利润FUSBTLSI
| Q4 25 | $2.1M | $-9.8M | ||
| Q3 25 | $1.9M | $-10.8M | ||
| Q2 25 | $155.0K | $-8.3M | ||
| Q1 25 | $1.8M | $-10.4M | ||
| Q4 24 | $1.7M | $-10.1M | ||
| Q3 24 | $2.2M | $-2.4M | ||
| Q2 24 | $2.1M | $-4.3M | ||
| Q1 24 | $2.1M | $-13.2M |
毛利率FUSBTLSI
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 83.5% | ||
| Q2 25 | — | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 87.6% | ||
| Q1 24 | — | 85.0% |
营业利润率FUSBTLSI
| Q4 25 | 28.1% | -24.8% | ||
| Q3 25 | 23.9% | -77.9% | ||
| Q2 25 | 1.6% | -65.4% | ||
| Q1 25 | 23.8% | -79.9% | ||
| Q4 24 | 23.8% | -91.8% | ||
| Q3 24 | 29.2% | -118.9% | ||
| Q2 24 | 27.4% | -111.0% | ||
| Q1 24 | 27.8% | -180.8% |
净利率FUSBTLSI
| Q4 25 | 20.4% | -73.9% | ||
| Q3 25 | 18.4% | -93.5% | ||
| Q2 25 | 1.5% | -73.9% | ||
| Q1 25 | 18.1% | -113.2% | ||
| Q4 24 | 17.6% | -122.4% | ||
| Q3 24 | 22.0% | -32.6% | ||
| Q2 24 | 21.2% | -58.8% | ||
| Q1 24 | 21.3% | -204.5% |
每股收益（稀释后）FUSBTLSI
| Q4 25 | $0.36 | $-0.22 | ||
| Q3 25 | $0.32 | $-0.96 | ||
| Q2 25 | $0.03 | $-0.27 | ||
| Q1 25 | $0.29 | $-0.39 | ||
| Q4 24 | $0.29 | $-0.38 | ||
| Q3 24 | $0.36 | $-0.12 | ||
| Q2 24 | $0.34 | $-0.21 | ||
| Q1 24 | $0.34 | $-0.60 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $73.5M | $20.4M |
| 总债务越低越好 | $10.9M | — |
| 股东权益账面价值 | $105.6M | $-33.9M |
| 总资产 | $1.2B | $35.3M |
| 负债/权益比越低杠杆越低 | 0.10× | — |
8季度趋势，按日历期对齐
现金及短期投资FUSBTLSI
| Q4 25 | $73.5M | $20.4M | ||
| Q3 25 | $54.7M | $22.7M | ||
| Q2 25 | $54.0M | $26.5M | ||
| Q1 25 | $56.0M | $13.0M | ||
| Q4 24 | $47.2M | $8.5M | ||
| Q3 24 | $82.3M | $11.3M | ||
| Q2 24 | $58.2M | $16.5M | ||
| Q1 24 | $60.2M | $4.0M |
总债务FUSBTLSI
| Q4 25 | $10.9M | — | ||
| Q3 25 | $10.9M | — | ||
| Q2 25 | $10.9M | — | ||
| Q1 25 | $10.9M | — | ||
| Q4 24 | $10.9M | — | ||
| Q3 24 | $10.9M | — | ||
| Q2 24 | $10.8M | — | ||
| Q1 24 | $10.8M | — |
股东权益FUSBTLSI
| Q4 25 | $105.6M | $-33.9M | ||
| Q3 25 | $104.2M | $-26.7M | ||
| Q2 25 | $101.9M | $-19.4M | ||
| Q1 25 | $101.2M | $-34.4M | ||
| Q4 24 | $98.6M | $-25.9M | ||
| Q3 24 | $98.5M | $-20.4M | ||
| Q2 24 | $93.8M | $-25.3M | ||
| Q1 24 | $92.3M | $-36.0M |
总资产FUSBTLSI
| Q4 25 | $1.2B | $35.3M | ||
| Q3 25 | $1.1B | $36.5M | ||
| Q2 25 | $1.1B | $41.3M | ||
| Q1 25 | $1.1B | $28.6M | ||
| Q4 24 | $1.1B | $24.0M | ||
| Q3 24 | $1.1B | $27.5M | ||
| Q2 24 | $1.1B | $32.4M | ||
| Q1 24 | $1.1B | $17.9M |
负债/权益比FUSBTLSI
| Q4 25 | 0.10× | — | ||
| Q3 25 | 0.10× | — | ||
| Q2 25 | 0.11× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | 0.11× | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.12× | — | ||
| Q1 24 | 0.12× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $12.3M | $-2.5M |
| 自由现金流经营现金流 - 资本支出 | $9.1M | $-2.5M |
| 自由现金流率自由现金流/营收 | 87.2% | -19.1% |
| 资本支出强度资本支出/营收 | 31.1% | 0.3% |
| 现金转化率经营现金流/净利润 | 5.79× | — |
| 过去12个月自由现金流最近4个季度 | $16.0M | $-19.1M |
8季度趋势，按日历期对齐
经营现金流FUSBTLSI
| Q4 25 | $12.3M | $-2.5M | ||
| Q3 25 | $4.2M | $-3.7M | ||
| Q2 25 | $3.9M | $-7.3M | ||
| Q1 25 | $1.8M | $-4.5M | ||
| Q4 24 | $7.8M | $-5.7M | ||
| Q3 24 | $1.9M | $-10.8M | ||
| Q2 24 | $2.5M | $-13.4M | ||
| Q1 24 | $825.0K | $-10.9M |
自由现金流FUSBTLSI
| Q4 25 | $9.1M | $-2.5M | ||
| Q3 25 | $3.6M | $-3.9M | ||
| Q2 25 | $1.6M | $-7.4M | ||
| Q1 25 | $1.7M | $-5.3M | ||
| Q4 24 | $5.7M | $-5.8M | ||
| Q3 24 | $1.3M | $-11.0M | ||
| Q2 24 | $2.3M | $-13.5M | ||
| Q1 24 | $-142.0K | $-10.9M |
自由现金流率FUSBTLSI
| Q4 25 | 87.2% | -19.1% | ||
| Q3 25 | 34.2% | -33.9% | ||
| Q2 25 | 16.0% | -66.1% | ||
| Q1 25 | 17.2% | -57.3% | ||
| Q4 24 | 58.2% | -69.7% | ||
| Q3 24 | 12.7% | -149.9% | ||
| Q2 24 | 23.5% | -183.1% | ||
| Q1 24 | -1.4% | -169.3% |
资本支出强度FUSBTLSI
| Q4 25 | 31.1% | 0.3% | ||
| Q3 25 | 5.9% | 1.9% | ||
| Q2 25 | 21.8% | 0.8% | ||
| Q1 25 | 0.7% | 8.2% | ||
| Q4 24 | 21.6% | 0.6% | ||
| Q3 24 | 6.6% | 2.3% | ||
| Q2 24 | 2.0% | 0.8% | ||
| Q1 24 | 9.8% | 1.0% |
现金转化率FUSBTLSI
| Q4 25 | 5.79× | — | ||
| Q3 25 | 2.18× | — | ||
| Q2 25 | 25.16× | — | ||
| Q1 25 | 0.99× | — | ||
| Q4 24 | 4.53× | — | ||
| Q3 24 | 0.87× | — | ||
| Q2 24 | 1.20× | — | ||
| Q1 24 | 0.39× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
